CorMedix Inc
NASDAQ:CRMD

Watchlist Manager
CorMedix Inc Logo
CorMedix Inc
NASDAQ:CRMD
Watchlist
Price: 14.89 USD 3.76% Market Closed
Market Cap: 1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+21%
Revenue
Forecast
+10%
Operating Income
Forecast
+17%
Net Income
Forecast
+23%

Wall Street
Price Targets

CRMD Price Targets Summary
CorMedix Inc

Wall Street analysts forecast CRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRMD is 16.73 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

CRMD Lowest Forecast
Wall Street Target
13.13 USD
12% Downside
CRMD Average Forecast
Wall Street Target
16.73 USD
12% Upside
CRMD Highest Forecast
Wall Street Target
21 USD
41% Upside
Lowest
Price Target
13.13 USD
12% Downside
Average
Price Target
16.73 USD
12% Upside
Highest
Price Target
21 USD
41% Upside
CorMedix Inc Competitors:
Price Targets
A
APPH
Apontis Pharma AG
14% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
39% Downside
SANOFI
Sanofi India Ltd
18% Upside
J
216080
Jetema Co Ltd
75% Upside
A
APPH
Apontis Pharma AG
14% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
39% Downside
SANOFI
Sanofi India Ltd
18% Upside
J
216080
Jetema Co Ltd
75% Upside
000538
Yunnan Baiyao Group Co Ltd
24% Upside
1681
Consun Pharmaceutical Group Ltd
6% Upside
VIRP
Virbac SA
20% Upside

Revenue
Forecast

Revenue Estimate
CorMedix Inc

The compound annual growth rate of CorMedix Inc's revenue for the next 3 years is 86%.

N/A
Past Growth
86%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
What are analyst estimates?

See Also

Summary
CRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRMD stock valuation using valuation multiples.
Wall Street Estimates
CRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRMD's stock price target?
Price Target
16.73 USD

According to Wall Street analysts, the average 1-year price target for CRMD is 16.73 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

What is CorMedix Inc's Revenue forecast?
Projected CAGR
86%

The compound annual growth rate of CorMedix Inc's revenue for the next 3 years is 86%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.